Abstract
The function of oncogenic lncRNA BLACAT1 has been studied in several types of cancer, while its role in cervical squamous cell carcinoma (CSCC) is unknown. We showed that BLACAT1 was upregulated in CSCC tissue comparing to adjacent non-cancer tissue of CSCC patients. BLACAT1 expression in CSCC tissues was not affected by HPV infection. Patients with higher BLACAT1 level in CSCC tissues showed a significantly lower overall 5-year survival rate. BLACAT1 expression was inversely correlated with several tumor-suppressive miRNAs, such as miR-424 and miR-143. miR-424 and miR-143 overexpression did not significantly affect BLACAT1, while BLACAT1 overexpression caused downregulated miR-424 and miR-143. Overexpression of miR-424 and miR-143 led to inhibited migration and invasion, while BLACAT1 overexpression led to promoted migration and invasion of CSCC cells. In addition, overexpression of miR-424 and miR-143 attenuated the effects of BLACAT1 overexpression. Therefore, BLACAT1 overexpression may promote CSCC by downregulating miR-424 and miR-143.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin. 2017;67(1):7–30.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
Wentzensen N, Schiffman M, Palmer T, et al. Triage of HPV positive women in cervical cancer screening[J]. J Clin Virol. 2016;76:S49–55.
Rodriguez-Carunchio L, Soveral I, Steenbergen RDM, et al. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis[J]. BJOG. 2015;122(1):119–27.
Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, et al. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study[J]. Lancet Oncol. 2018;19(12):1569–78.
Machalek DA, Wark JD, Tabrizi SN, Hopper JL, Bui M, Dite GS, et al. Genetic and environmental factors in invasive cervical cancer: design and methods of a classical twin study[J]. Twin Res Hum Genet. 2017;20(1):10–8.
Wang SS, Gonzalez P, Yu K, Porras C, Li Q, Safaeian M, et al. Common genetic variants and risk for HPV persistence and progression to cervical cancer[J]. PLoS One. 2010;5(1):e8667.
Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view[J]. RNA Biol. 2012;9(6):703–19.
Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research?[J]. Oncogene. 2012;31(43):4577–87.
Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine[J]. Mod Pathol. 2013;26(2):155–65.
Aalijahan H, Ghorbian S. Long non-coding RNAs, and cervical cancer. Exp Mol Pathol. 2019;106:7–16.
Huang FX, Chen HJ, Zheng FX, Gao ZY, Sun PF, Peng Q, et al. LncRNA BLACAT1 is involved in chemoresistance of non-small cell lung cancer cells by regulating autophagy[J]. Int J Oncol. 2018;54(1):339–47.
Wu X, Zheng Y, Han B, Dong X. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361[J]. Biomed Pharmacother. 2018;99:832–8.
Shan D, Shang Y, Hu T. Long noncoding RNA BLACAT1 promotes cell proliferation and invasion in human cervical cancer. Oncol Lett. 2018;15(3):3490–5.
Wang CH, Li YH, Tian HL, Bao XX, Wang ZM. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway[J]. Eur Rev Med Pharmacol Sci. 2018;22(10):3002–9.
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F, et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer[J]. Oncogene. 2013;32(8):976–87.
Liu L, Yu X, Guo X, Tian Z, Su M, Long Y, et al. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2[J]. Mol Med Rep. 2012;5(3):753–60.
Lau YM, Cheung TH, Yeo W, Mo F, Yu MY, Lee KM, et al. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment[J]. PLoS One. 2015;10(4):e0122557.
Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA–lncRNA interactions[M]//long non-coding RNAs. New York, NY: Humana Press; 2016. p. 271–86.
Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development[J]. Biochim Biophys Acta Gene Regul Mech 2016, 1859.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Electronic supplementary material
Supplemental file 1
Original images of cell invasion and migration (DOCX 14494 kb)
Rights and permissions
About this article
Cite this article
Cheng, H., Tian, J., Wang, C. et al. LncRNA BLACAT1 Is Upregulated in Cervical Squamous Cell Carcinoma (CSCC) and Predicts Poor Survival. Reprod. Sci. 27, 585–591 (2020). https://doi.org/10.1007/s43032-019-00058-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-019-00058-9